Product Highlights

 Export Full List
In 2006 Biomedcode was founded as a spin-off company of one of the highest-ranked research institutes in Greece, and since then Biomedcode has built on the scientific expertise of its founders and its highly specialized personnel to offer scientific consultation and top quality, customized solutions using worldwide unique mouse disease models. Since 2006, Biomedcode has supported the development of over 60 biosimilars, 21 novel biologics, 22 small molecule inhibitors, and 8 novel technological platforms. Building on this experience, Biomedcode is the ideal partner to offer special services and solutions to the Pharma sector in alignment with its needs for a more efficient and speedier drug development process.
Pharmaceutical Supplies